Brief

"On 15/04/2025, the Italian Medicines Agency (AIFA) issued an update regarding AIFA-Regions working group: shared calculation method for the class economic impact of glyphozines. The discussion focused on the transition of glyphozine medicines from direct distribution to pharmacy distribution, as per the Budget Law 2024, with a constructive comparison leading to the sharing of a calculation method to evaluate the economic impact of this change." The AIFA-Regions working group will continue to discuss data on spending elaborated after the price renegotiation of this class of medicines, expected shortly.

This content is restricted.

Highlights content goes here...

This content is restricted.

Italian Medicines Agency (AIFA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies